Raises 2023 Annual Revenue Guidance to $75 Million – $77 Million   BELGRADE, Mont. , Aug. 01, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported